Transgene Biotek informs about quarterly statement of investor complaint

13 Jan 2016 Evaluate

Transgene Biotek has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.08 0.28 (10.00%)
30-Dec-2025 11:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6995.50
Max Healthcare Inst 1038.50
Narayana Hrudayalay 1816.85
Aster DM Healthcare 600.90
Global Health 1154.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×